Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085437 (
bacterial meningitis
)
4,038
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CXCL5
(epithelial-cell-derived neutrophil-activating protein (ENA-)78) is a CXC-chemokine that specifically acts on neutrophils. To obtain insight into the extent of local presence and action of
CXCL5
during
bacterial meningitis
, we measured its concentrations in cerebrospinal fluid (CSF) of patients with culture-proven
bacterial meningitis
(n=14), aseptic meningitis (n=6), and controls (n=32) and compared these results with levels of other CXC-chemokines, CXCL8- (interleukin-8) and CXCL1-related oncogene (growth-related oncogene (GRO)-alpha). Patients with
bacterial meningitis
had profoundly elevated CSF concentrations of all three chemokines.
CXCL5
was not detectable in patients with aseptic meningitis or control subjects. CSF from patients with
bacterial meningitis
exerted chemotactic activity towards neutrophils, which was partially inhibited by neutralizing antibodies against
CXCL5
and CXCL8, but not CXCL1. CSF from controls exerted minor chemotactic activity, which could be strongly enhanced by the addition of recombinant
CXCL5
, CXCL8 or CXCL1. During
bacterial meningitis
,
CXCL5
is elevated in CSF, where it is involved in the recruitment of neutrophils to the central nervous system.
...
PMID:Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. 1464 41